T1	Age 2 13	66-year-old
T2	Sex 14 17	man
T3	Clinical_event 22 30	admitted
E1	Clinical_event:T3 
T4	Nonbiological_location 40 48	Hospital
R1	MODIFY Arg1:T4 Arg2:E1	
T5	Date 52 65	November 2008
E2	Date:T5 
T6	Sign_symptom 71 83	splenomegaly
E3	Sign_symptom:T6 
T7	Diagnostic_procedure 92 106	red cell count
E4	Diagnostic_procedure:T7 
T9	Diagnostic_procedure 122 142	serum erythropoietin
E5	Diagnostic_procedure:T9 
T11	Diagnostic_procedure 151 171	Cytogenetic analysis
E6	Diagnostic_procedure:T11 
T12	Diagnostic_procedure 193 202	karyotype
E7	Diagnostic_procedure:T12 
R6	SUB_PROCEDURE Arg1:E7 Arg2:E6	
T15	Diagnostic_procedure 204 221	Molecular studies
E8	Diagnostic_procedure:T15 
T22	Disease_disorder 351 353	PV
E12	Disease_disorder:T22 
#1	AnnotatorNotes E12	Polycythemia Vera
T8	Lab_value 87 91	high
E13	Lab_value:T8 
R2	MODIFY Arg1:E13 Arg2:E4	
T10	Lab_value 112 121	subnormal
E14	Lab_value:T10 
R3	MODIFY Arg1:E14 Arg2:E5	
T13	Lab_value 181 187	normal
E15	Lab_value:T13 
T14	Lab_value 188 192	male
E16	Lab_value:T14 
R4	MODIFY Arg1:E16 Arg2:E7	
R5	MODIFY Arg1:E15 Arg2:E7	
T16	Sign_symptom 244 266	BCR-ABL1 rearrangement
E9	Sign_symptom:T16 
A1	POLARITY E9 NEG
T17	Sign_symptom 285 303	JAK2V617F mutation
E10	Sign_symptom:T17 
T18	Lab_value 312 334	allele burden of 44.9%
E11	Lab_value:T18 
R7	MODIFY Arg1:E11 Arg2:E10	
T19	Diagnostic_procedure 395 415	bone marrow analysis
E17	Diagnostic_procedure:T19 
T20	Detailed_description 381 394	morphological
R8	MODIFY Arg1:T20 Arg2:E17	
T21	Detailed_description 433 450	WHO 2008 criteria
R9	MODIFY Arg1:T21 Arg2:E17	
T23	Medication 479 486	aspirin
E18	Medication:T23 
T24	Medication 488 499	hydroxyurea
E19	Medication:T24 
T25	Therapeutic_procedure 505 517	phlebotomies
E20	Therapeutic_procedure:T25 
T26	Date 553 568	Six years later
E21	Date:T26 
T27	Diagnostic_procedure 583 593	ultrasound
E22	Diagnostic_procedure:T27 
T28	Biological_structure 573 582	abdominal
R10	MODIFY Arg1:T28 Arg2:E22	
T29	Sign_symptom 652 664	infiltration
E23	Sign_symptom:T29 
T30	Biological_structure 640 651	perinephric
T31	Detailed_description 630 639	bilateral
T32	Detailed_description 624 629	dense
R11	MODIFY Arg1:T31 Arg2:E23	
R12	MODIFY Arg1:T30 Arg2:E23	
R13	MODIFY Arg1:T32 Arg2:E23	
T33	Diagnostic_procedure 723 725	CT
E24	Diagnostic_procedure:T33 
T34	Diagnostic_procedure 702 721	computed tomography
E25	Diagnostic_procedure:T34 
T35	Biological_structure 691 701	whole-body
R14	MODIFY Arg1:T35 Arg2:E25	
R15	IDENTICAL Arg1:E24 Arg2:E25	
T36	Diagnostic_procedure 739 797	fluotine-18 fluordeoxyglucose positron emission tomography
E26	Diagnostic_procedure:T36 
T37	Diagnostic_procedure 799 808	F-FDG-PET
E27	Diagnostic_procedure:T37 
R16	IDENTICAL Arg1:E27 Arg2:E26	
T38	Diagnostic_procedure 838 852	glucose uptake
E28	Diagnostic_procedure:T38 
T39	Lab_value 828 837	increased
E29	Lab_value:T39 
R17	MODIFY Arg1:E29 Arg2:E28	
T40	Biological_structure 860 904	medullary channels of both humeri and femurs
R18	MODIFY Arg1:T40 Arg2:E28	
T41	Diagnostic_procedure 920 940	bone marrow analysis
E30	Diagnostic_procedure:T41 
T42	Detailed_description 906 919	Morphological
R19	MODIFY Arg1:T42 Arg2:E30	
T43	Disease_disorder 977 979	PV
E31	Disease_disorder:T43 
T44	Disease_disorder 1039 1047	fibrosis
E32	Disease_disorder:T44 
T45	Biological_structure 1027 1038	bone marrow
R20	MODIFY Arg1:T45 Arg2:E32	
T46	Diagnostic_procedure 1071 1087	EUMNET consensus
E33	Diagnostic_procedure:T46 
T47	Lab_value 1049 1053	MF-0
E34	Lab_value:T47 
R21	MODIFY Arg1:E34 Arg2:E33	
T48	Diagnostic_procedure 1100 1120	cytogenetic analysis
E35	Diagnostic_procedure:T48 
T49	Diagnostic_procedure 1157 1166	karyotype
E36	Diagnostic_procedure:T49 
T50	Lab_value 1152 1156	male
E37	Lab_value:T50 
R22	MODIFY Arg1:E37 Arg2:E36	
T51	Lab_value 1168 1222	47,XY,+9[2/20],47,XY,add(6)(p25),+9[2/20],46,XY[16/20]
E38	Lab_value:T51 
T52	Diagnostic_procedure 1228 1247	histological nature
E39	Diagnostic_procedure:T52 
T53	Sign_symptom 1267 1279	infiltration
E40	Sign_symptom:T53 
T54	Biological_structure 1255 1266	perinephric
R23	MODIFY Arg1:T54 Arg2:E40	
T55	Diagnostic_procedure 1324 1330	biopsy
E41	Diagnostic_procedure:T55 
T56	Detailed_description 1319 1323	core
T57	Sign_symptom 1338 1344	lesion
E42	Sign_symptom:T57 
T58	Detailed_description 1309 1318	CT-guided
R24	MODIFY Arg1:T56 Arg2:E41	
R25	MODIFY Arg1:T58 Arg2:E41	
T59	Diagnostic_procedure 1346 1368	Morphological analysis
E43	Diagnostic_procedure:T59 
T60	Diagnostic_procedure 1443 1447	CD68
E44	Diagnostic_procedure:T60 
T61	Sign_symptom 1402 1419	foamy histiocytes
E45	Sign_symptom:T61 
T62	Lab_value 1430 1438	positive
E46	Lab_value:T62 
T63	Diagnostic_procedure 1492 1496	CD1a
E47	Diagnostic_procedure:T63 
T64	Diagnostic_procedure 1501 1505	S100
E48	Diagnostic_procedure:T64 
T65	Disease_disorder 1521 1529	fibrosis
E49	Disease_disorder:T65 
T66	Lab_value 1452 1460	negative
E50	Lab_value:T66 
R26	MODIFY Arg1:E46 Arg2:E44	
R27	MODIFY Arg1:E45 Arg2:E44	
R28	MODIFY Arg1:E45 Arg2:E47	
R29	MODIFY Arg1:E45 Arg2:E48	
R30	MODIFY Arg1:E50 Arg2:E47	
R31	MODIFY Arg1:E50 Arg2:E48	
T67	Sign_symptom 1560 1570	infiltrate
E51	Sign_symptom:T67 
T68	Detailed_description 1543 1559	lympho-monocytic
T69	Detailed_description 1536 1542	scanty
R32	MODIFY Arg1:T68 Arg2:E51	
R33	MODIFY Arg1:T69 Arg2:E51	
T70	Sign_symptom 1615 1633	BRAFV600E mutation
E52	Sign_symptom:T70 
T71	Disease_disorder 1656 1659	ECD
E53	Disease_disorder:T71 
#2	AnnotatorNotes E53	Erdheim-Chester disease
T72	Diagnostic_procedure 1669 1695	magnetic resonance imaging
E54	Diagnostic_procedure:T72 
T73	Diagnostic_procedure 1697 1700	MRI
E55	Diagnostic_procedure:T73 
R34	IDENTICAL Arg1:E55 Arg2:E54	
T74	Biological_structure 1661 1668	Cardiac
R35	MODIFY Arg1:T74 Arg2:E54	
T75	Sign_symptom 1726 1738	infiltration
E56	Sign_symptom:T75 
T76	Detailed_description 1711 1725	pseudo-tumoral
R36	MODIFY Arg1:T76 Arg2:E56	
T77	Biological_structure 1746 1767	atrioventricular wall
R37	MODIFY Arg1:T77 Arg2:E56	
T78	Diagnostic_procedure 1777 1786	bone scan
E57	Diagnostic_procedure:T78 
T79	Sign_symptom 1830 1836	uptake
E58	Sign_symptom:T79 
T80	Detailed_description 1794 1817	symmetrically irregular
R38	MODIFY Arg1:T80 Arg2:E58	
T81	Biological_structure 1844 1867	long bones of the limbs
R39	MODIFY Arg1:T81 Arg2:E58	
T82	Disease_disorder 1884 1887	ECD
E59	Disease_disorder:T82 
T83	Diagnostic_procedure 1949 1956	imaging
E60	Diagnostic_procedure:T83 
T84	Biological_structure 1939 1948	pulmonary
T85	Biological_structure 1926 1934	cerebral
R40	MODIFY Arg1:T84 Arg2:E60	
R41	MODIFY Arg1:T85 Arg2:E60	
T86	Lab_value 1962 1970	negative
E61	Lab_value:T86 
R42	MODIFY Arg1:E61 Arg2:E60	
T87	Disease_disorder 2039 2042	ECD
E62	Disease_disorder:T87 
T88	Medication 2088 2110	interferon (IFN)-alpha
E63	Medication:T88 
T89	Detailed_description 2078 2087	pegylated
R43	MODIFY Arg1:T89 Arg2:E63	
T90	Date 2116 2130	after 3 months
E64	Date:T90 
T91	Diagnostic_procedure 2161 2171	ultrasound
E65	Diagnostic_procedure:T91 
T92	Biological_structure 2151 2160	abdominal
R44	MODIFY Arg1:T92 Arg2:E65	
T93	Sign_symptom 2245 2257	infiltration
E66	Sign_symptom:T93 
A2	POLARITY E66 NEG
T94	Diagnostic_procedure 2288 2305	blood cell counts
E67	Diagnostic_procedure:T94 
T95	Lab_value 2267 2280	normalization
E68	Lab_value:T95 
R45	MODIFY Arg1:E68 Arg2:E67	
T96	Biological_structure 2233 2244	perinephric
T97	Detailed_description 2223 2232	bilateral
T98	Detailed_description 2217 2222	dense
R46	MODIFY Arg1:T98 Arg2:E66	
R47	MODIFY Arg1:T97 Arg2:E66	
R48	MODIFY Arg1:T96 Arg2:E66	
*	OVERLAP E1 E2 E3 E4 E5 E6 E8 E9 E10 E12 E17
R49	BEFORE Arg1:E17 Arg2:E18	
*	OVERLAP E18 E19 E20
R50	BEFORE Arg1:E20 Arg2:E21	
*	OVERLAP E21 E22 E23 E25 E26 E28 E30 E31 E32 E33 E35 E39 E40 E41 E42 E43 E45 E44 E47 E48 E49 E51 E52 E53 E54 E56 E57 E58 E59 E60 E62
R51	SUB_PROCEDURE Arg1:E36 Arg2:E35	
R52	MODIFY Arg1:E38 Arg2:E36	
R53	BEFORE Arg1:E62 Arg2:E63	
R54	BEFORE Arg1:E63 Arg2:E64	
*	OVERLAP E64 E65 E66 E67
